株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オリゴヌクレオチド合成の世界市場:市場規模・シェア・動向・成長率・将来予測 (2023年まで)

Global Oligonucleotide Synthesis Market Size, Share, Development, Growth and Demand Forecast to 2023

発行 Prescient & Strategic Intelligence Private Limited 商品コード 536301
出版日 ページ情報 英文 141 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
オリゴヌクレオチド合成の世界市場:市場規模・シェア・動向・成長率・将来予測 (2023年まで) Global Oligonucleotide Synthesis Market Size, Share, Development, Growth and Demand Forecast to 2023
出版日: 2017年02月01日 ページ情報: 英文 141 Pages
概要

当レポートでは、世界のオリゴヌクレオチド合成市場について分析し、オリゴヌクレオチド合成の特徴や用途、市場の基本構造および促進・抑制要因、全体的な市場規模の動向見通し、製品別・用途別・エンドユーザー別・地域別の詳細動向、市場の競争状況・求心力、主要企業のプロファイル・事業戦略などを調査しております。

第1章 分析の背景事情

第2章 分析手法

第3章 イントロダクション

  • 市場区分:製品別、用途別、エンドユーザー別
  • 市場のダイナミクス
    • 市場促進要因
      • オリゴヌクレオチド合成技術の近年の進歩
      • 政府支援の拡大
      • 合成生物学での研究活動の活発化
      • がん・感染症の患者増加
      • 今後の市場成長への影響度
    • 市場抑制要因
      • 厳格な規制・要求
      • オリゴヌクレオチドの大規模な合成技術の欠如
      • 今後の市場成長への影響度
    • 市場機会
      • 個別化医療への関心増大
      • 新興国市場でのオリゴヌクレオチド合成の普及
  • ポーターのファイブフォース分析

第4章 市場規模とその予測:製品別

  • 合成ヌクレオチド
    • 地域別
    • 種類別 (製品、サービス)
  • ヌクレオチド合成用試薬
  • ヌクレオチド合成用装置

第5章 市場規模とその予測:用途別

  • 研究用
  • 診断用
  • 治療用

第6章 市場規模とその予測:エンドユーザー別

  • 教育・研究機関
  • 診断試験所
  • 製薬企業・バイオテクノロジー企業

第7章 市場規模とその予測:地域別

  • 北米市場
    • 製品別、用途別、エンドユーザー別
  • 欧州市場
  • アジア太平洋地域市場
  • ラテンアメリカ市場
  • 中東・アフリカ市場

第8章 競争環境

  • 主要企業の製品:相互比較
  • 競争戦略の展開状況
    • 企業合併・買収 (M&A)

第9章 企業プロファイル

  • LGC Biosearch Technologies, Inc.
    • 事業概要
    • 主要製品・サービス
  • Bioautomation Corporation
  • Integrated DNA Technologies, Inc.
  • GeneDesign, Inc.
  • Trilink Biotechnologies LLC
  • Merck KGaA
  • Eurofins Scientific SE
  • Thermo Fisher Scientific Inc.
  • General Electric Company
  • Eurogentec S.A.

第10章 付録

  • 略語一覧

図表一覧

目次

Market Overview:

Oligonucleotide synthesis refers to the chemical synthesis of short fragments of single stranded deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). These short fragments of single stranded DNA or RNA are called oligomers, which are characterized by sequence of nucleotides residues. These nucleotide residues make up entire oligomers or short DNA or RNA molecule. The global oligonucleotide synthesis market is segmented on the basis of product, application and end user.

The global market on the basis of product is further segmented into synthesized oligonucleotides, reagents and equipment. Synthesized oligonucleotide is the largest segment of the global oligonucleotide synthesis market.

The global market on the basis of application is further segmented into research, diagnostic and therapeutic, with research being the largest application of the market.

The global market on the basis of end user is further segmented into academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies and others.

Market Dynamics:

The global oligonucleotide synthesis market is expected to witness a CAGR of 10.5% during the forecast period, to reach $2,744.5 million by 2023. Recent technological advancements in oligonucleotide synthesis and increasing support from government organizations are the key drivers of the global oligonucleotide synthesis market. The market is faced by challenges such as stringent regulations and lack of techniques for large scale synthesis of oligonucleotide. Growing focus on personalized medicine will create enormous revenue generation opportunities for the manufacturers in this market.

Opportunities:

The revenue of global market is expected to be positively impacted by growing focus on personalized medicine. Personalized medicine offers tailored medical treatment to individual characteristics, needs and preferences of patients. Oligonucleotide synthesis helps in offering personalized solutions to ill patients. With the advancement in oligonucleotide synthesis, patients can be treated and diagnosed more precisely and effectively, meeting their individual needs.

The increasing compliance for oligonucleotide synthesis in the emerging economies is expected to provide huge growth potential for the market during the forecast years. Countries, such as China and India, have a huge market potential, as the healthcare industry is witnessing significant growth in these countries. Moreover, manufacturing of oligonucleotide synthesis products in the developing regions tends to decrease the overall cost of manufacturing, thus, reducing the cost of the product without altering its quality. High research and development cost and increasing pressure from payers and providers for reducing healthcare cost are leading to shift of interest from developed regions to developing economies for exploration of new ways of drug discovery and development.

Growth Drivers:

Technological advancements have led to the development of oligonucleotide synthesis products. The synthesis of oligonucleotides has gone under tremendous advancements, which leads to cost-effective and rapid synthesis of oligomers. Improvement in synthesis techniques such as development of high throughput synthesizers, new sets of protecting amino groups and better coupling reagents has revolutionized the chemistry for oligonucleotide synthesis. Along with efficient nucleotide assembly method and enzymatic error correction, these technologies are bolstering the global oligonucleotide synthesis market.

Increasing participation of public and private research entities in synthetic biology research activities poses a positive impact on the growth of the global synthetic biology market. The increasing number of public and private entities involved in synthetic biology research has fueled the demand for oligonucleotide synthesis technologies and related equipment. Another key driver for this market is the increasing burden of cancer and infectious diseases.

Competitive Landscape:

Some of the key players in the global market include LGC Biosearch Technologies, Inc., Bioautomation Corporation, Integrated DNA Technologies, Inc., GeneDesign, Inc., Trilink Biotechnologies LLC, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., General Electric Company and Eurogentec S.A.

Scope for Customization:

P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

  • Period of Analysis - Increase in the study period, including historic and forecast years

Geographical Analysis - Increase in country coverage:

Segment Analysis - More granular coverage related to:

  • Further analysis of product and service under synthesized oligonucleotides by region
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment

Table of Content

Chapter 1. Research Background

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Research Scope
    • 1.3.1. Market segmentation by product
    • 1.3.2. Market segmentation by application
    • 1.3.3. Market segmentation by end user
    • 1.3.4. Market segmentation by geography
    • 1.3.5. Analysis Period
    • 1.3.6. Market Data Reporting Unit
      • 1.3.6.1. Value
  • 1.4. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
  • 2.2. Primary Research
    • 2.2.1. Breakdown of Primary Research Respondents
      • 2.2.1.1. By Region
      • 2.2.1.2. By Industry Participants
      • 2.2.1.3. By Company Type
  • 2.3. Market Size Estimation
  • 2.4. Market Breakdown and Data Triangulation
  • 2.5. Assumptions for the Study

Chapter 3. Introduction

  • 3.1. Market Segmentation
    • 3.1.1. Overview by Product
      • 3.1.1.1. Synthesized oligonucleotides
        • 3.1.1.1.1. Synthesized oligonucleotides market by product
        • 3.1.1.1.1.1. Primers
        • 3.1.1.1.1.2. Probes
        • 3.1.1.1.1.3. Large-scale synthesis oligonucleotides
        • 3.1.1.1.1.4. Intermediate-scale synthesis oligonucleotides
        • 3.1.1.1.1.5. Linkers. adaptors
        • 3.1.1.1.2. Synthesized oligonucleotides market by service
        • 3.1.1.1.2.1. Custom oligonucleotides
        • 3.1.1.1.2.2. Pre-designed oligonucleotides
      • 3.1.1.2. Reagents
      • 3.1.1.3. Equipment
    • 3.1.2. Overview by Application
      • 3.1.2.1. Research
      • 3.1.2.2. Diagnostic
      • 3.1.2.3. Therapeutic
    • 3.1.3. Overview by End User
      • 3.1.3.1. Academic research institutes
      • 3.1.3.2. Diagnostic laboratories
      • 3.1.3.3. Pharmaceutical. biotechnology companies
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Recent advances in oligonucleotide synthesis
      • 3.2.1.2. Increasing support from government organizations
      • 3.2.1.3. Increasing research activities in synthetic biology
      • 3.2.1.4. Increasing burden of cancer and infectious diseases
      • 3.2.1.5. Impact analysis of drivers on market forecast
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent regulatory requirements
      • 3.2.2.2. Lack of techniques for large scale synthesis of oligonucleotide
      • 3.2.2.3. Impact analysis of restraints on market forecast
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing focus on personalized medicine
      • 3.2.3.2. Increasing compliance for oligonucleotide synthesis in emerging markets
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining power of buyers
    • 3.3.2. Bargaining power of suppliers
    • 3.3.3. Threat of new entrants
    • 3.3.4. Intensity of rivalry
    • 3.3.5. Threat of substitutes

Chapter 4. Market Size and Forecast by Product

  • 4.1. Global Synthesized Oligonucleotides Market
    • 4.1.1. Global synthesized oligonucleotides market, by region
    • 4.1.2. Global synthesized oligonucleotides market, by type
      • 4.1.2.1. Global synthesized oligonucleotides market, by product
      • 4.1.2.2. Global synthesized oligonucleotides market, by service
  • 4.2. Global Oligonucleotide Synthesis Reagents Market
    • 4.2.1. Global oligonucleotide synthesis reagents market, by region
  • 4.3. Global Oligonucleotide Synthesis Equipment Market
    • 4.3.1. Global oligonucleotide synthesis equipment market, by region

Chapter 5. Market Size and Forecast by Application

  • 5.1. Global Oligonucleotide Synthesis Market for Research, by Region
  • 5.2. Global Oligonucleotide Synthesis Market for Diagnostic, by Region
  • 5.3. Global Oligonucleotide Synthesis Market for Therapeutic, by Region

Chapter 6. Market Size and Forecast by End User

  • 6.1. Global Oligonucleotide Synthesis Market for Academic Research Institutes, by Region
  • 6.2. Global Oligonucleotide Synthesis Market for Diagnostic Laboratories, by Region
  • 6.3. Global Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies, by Region

Chapter 7. Market Size and Forecast by Geography

  • 7.1. North America Oligonucleotide Synthesis Market
    • 7.1.1. North America Oligonucleotide Synthesis Market, by Product
    • 7.1.2. North America Oligonucleotide Synthesis Market, by Application
    • 7.1.3. North America Oligonucleotide Synthesis Market, by End User
  • 7.2. Europe Oligonucleotide Synthesis Market
    • 7.2.1. Europe Oligonucleotide Synthesis Market, by Product
    • 7.2.2. Europe Oligonucleotide Synthesis Market, by Application
    • 7.2.3. Europe Oligonucleotide Synthesis Market, by End User
  • 7.3. Asia-Pacific (APAC) Oligonucleotide Synthesis Market
    • 7.3.1. APAC Oligonucleotide Synthesis Market, by Product
    • 7.3.2. APAC Oligonucleotide Synthesis Market, by Application
    • 7.3.3. APAC Oligonucleotide Synthesis Market, by End User
  • 7.4. Latin America (LATAM) Oligonucleotide Synthesis Market
    • 7.4.1. LATAM Oligonucleotide Synthesis Market, by Product
    • 7.4.2. LATAM Oligonucleotide Synthesis Market, by Application
    • 7.4.3. LATAM Oligonucleotide Synthesis Market, by End User
  • 7.5. Middle East and Africa (MEA) Oligonucleotide Synthesis Market
    • 7.5.1. MEA Oligonucleotide Synthesis Market, by Product
    • 7.5.2. MEA Oligonucleotide Synthesis Market, by Application
    • 7.5.3. MEA Oligonucleotide Synthesis Market, by End User

Chapter 8. Competitive Landscape

  • 8.1. Benchmarking of Oligonucleotide Synthesis Products by Key Players
  • 8.2. Global Strategic Developments
    • 8.2.1. Mergers and Acquisitions

Chapter 9. Company Profiles

  • 9.1. LGC Biosearch Technologies, Inc.
    • 9.1.1. Business overview
    • 9.1.2. Product and service offerings
  • 9.2. Bioautomation Corporation
    • 9.2.1. Business overview
    • 9.2.2. Product and service offerings
  • 9.3. Integrated DNA Technologies, Inc.
    • 9.3.1. Business overview
    • 9.3.2. Product and service offerings
  • 9.4. GeneDesign, Inc.
    • 9.4.1. Business overview
    • 9.4.2. Product and service offerings
  • 9.5. Trilink Biotechnologies LLC
    • 9.5.1. Business overview
    • 9.5.2. Product and service offerings
  • 9.6. Merck KGaA
    • 9.6.1. Business overview
    • 9.6.2. Product and service offerings
  • 9.7. Eurofins Scientific SE
    • 9.7.1. Business overview
    • 9.7.2. Product and service offerings
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Business overview
    • 9.8.2. Product and service offerings
  • 9.9. General Electric Company
    • 9.9.1. Business overview
    • 9.9.2. Product and service offerings
  • 9.10. Eurogentec S.A.
    • 9.10.1. Business overview
    • 9.10.2. Product and service offerings

Chapter 10. Appendix

  • 10.1. Abbreviations

LIST OF TABLES

  • TABLE 1: ANALYSIS PERIOD OF THE STUDY
  • TABLE 2: NUMBER OF WORLDWIDE MORTALITIES DUE TO VARIOUS DISEASES
  • TABLE 3: DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4: MAJOR NIH GUIDELINES IN THE U.S., BY EXPERIMENT TYPE
  • TABLE 5: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 6: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 7: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 8: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2013 - 2016)
  • TABLE 9: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2017 - 2023)
  • TABLE 10: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2013 - 2016)
  • TABLE 11: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2017 - 2023)
  • TABLE 12: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 13: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 14: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2013 - 2016)
  • TABLE 15: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2017 - 2023)
  • TABLE 16: GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2013 - 2016)
  • TABLE 17: GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2017 - 2023)
  • TABLE 18: GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2013 - 2016)
  • TABLE 19: GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2017 - 2023)
  • TABLE 20: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 21: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 22: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2013 - 2016)
  • TABLE 23: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2017 - 2023)
  • TABLE 24: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2013 - 2016)
  • TABLE 25: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2017 - 2023)
  • TABLE 26: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2013 - 2016)
  • TABLE 27: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2017 - 2023)
  • TABLE 28: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 29: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 30: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2013 - 2016)
  • TABLE 31: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2017 - 2023)
  • TABLE 32: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 - 2016)
  • TABLE 33: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2017 - 2023)
  • TABLE 34: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2013 - 2016)
  • TABLE 35: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2017 - 2023)
  • TABLE 36: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 37: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 38: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 39: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 40: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 41: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 42: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 43: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 44: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 45: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 46: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 47: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 48: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 49: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 50: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 51: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 52: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 53: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 54: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 55: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 56: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 57: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 58: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 59: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 60: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2016)
  • TABLE 61: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2017 - 2023)
  • TABLE 62: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2016)
  • TABLE 63: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2017 - 2023)
  • TABLE 64: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2016)
  • TABLE 65: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2017 - 2023)
  • TABLE 66: LGC BIOSEARCH TECHNOLOGIES, INC. - AT A GLANCE
  • TABLE 67: BIOAUTOMATION CORPORATION - AT A GLANCE
  • TABLE 68: INTEGRATED DNA TECHNOLOGIES, INC. - AT A GLANCE
  • TABLE 69: GENEDESIGN, INC. - AT A GLANCE
  • TABLE 70: TRILINK BIOTECHNOLOGIES LLC - AT A GLANCE
  • TABLE 71: MERCK KGAA - AT A GLANCE
  • TABLE 72: EUROFINS SCIENTIFIC SE - AT A GLANCE
  • TABLE 73: THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 74: GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 75: EUROGENTEC S.A.- AT A GLANCE

LIST OF FIGURES

  • FIG. 1: RESEARCH SCOPE FOR GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIG. 2: RESEARCH METHODOLOGY FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIG. 3: REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG. 4: BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG. 5: BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG. 6: BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG. 7: DATA TRIANGULATION APPROACH FOR THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIG. 8: PORTERS FIVE FORCES ANALYSIS OF THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIG. 9: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY PRODUCT (2016)
  • FIG. 10: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 11: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY REGION, $M (2013 - 2023)
  • FIG. 12: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY TYPE, $M (2013 - 2023)
  • FIG. 13: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 14: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE, $M (2013 - 2023)
  • FIG. 15: GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, $M (2013 - 2023)
  • FIG. 16: GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, $M (2013 - 2023)
  • FIG. 17: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY APPLICATION (2016)
  • FIG. 18: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 19: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH, BY REGION, $M (2013 - 2023)
  • FIG. 20: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC, BY REGION, $M (2013 - 2023)
  • FIG. 21: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC, BY REGION, $M (2013 - 2023)
  • FIG. 22: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SPLIT, BY END USER (2016)
  • FIG. 23: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
  • FIG. 24: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, $M (2013 - 2023)
  • FIG. 25: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, $M (2013 - 2023)
  • FIG. 26: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, $M (2013 - 2023)
  • FIG. 27: WORLDWIDE MAJOR MARKETS FOR OLIGONUCLEOTIDE SYNTHESIS
  • FIG. 28: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIG. 29: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 30: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 31: NORTH AMERICA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
  • FIG. 32: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIG. 33: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 34: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 35: EUROPE OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
  • FIG. 36: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIG. 37: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 38: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 39: APAC OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
  • FIG. 40: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIG. 41: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 42: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 43: LATAM OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
  • FIG. 44: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIG. 45: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, $M (2013 - 2023)
  • FIG. 46: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, $M (2013 - 2023)
  • FIG. 47: MEA OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, $M (2013 - 2023)
Back to Top